@misc{Cierniewski_Czesław_S._Current_1996, author={Cierniewski, Czesław S. and Stasiak, Marta}, volume={34}, number={3}, copyright={Creative Commons Attribution BY-SA 4.0 license}, journal={Biotechnologia, vol.34, 3 (1996)-.}, howpublished={online}, year={1996}, publisher={Committee on Biotechnology PAS}, publisher={Institute of Bioorganic Chemistry PAS}, language={pol}, abstract={This lecture consists of three parts, the first one gives a summary of mechanisms regulatinghemostasis and fibrinolysis, the second — discusses potential target molecules for therapeuticintervention, and the third one describes recent studies on selective inhibition of certain pathophysiological processes by molecules designed to prevent cardiovascular problems. Thus, acritical review of current trends in biotechnology of drugs which recently have been designedand tested to improve survival of patients with different cardiovascular diseases is provided.}, type={Text}, title={Current trends in biotechnology of drugs applied in cardiovascular diseases— recombinant proteins, peptide analogues and antisense oligonucleotides}, URL={http://rcin.org.pl/Content/146803/PDF/POZN271_182448_biotechnologia-1996-no3-cierniewski.pdf}, keywords={biotechnology}, }